APGE
Apogee Therapeutics, Inc. · Healthcare · Biotechnology
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +12 | 31.81M | $4.18B | +21 | −9 |
| Q1 2026 | 96 | +7 | 41.18M | $3.45B | +13 | −6 |
| Q4 2025 | 88 | 0 | 38.24M | $2.89B | — | — |
| Q3 2025 | 17 | -2 | 25.40M | $1.01B | — | −2 |
| Q2 2025 | 16 | +1 | 22.08M | $959.13M | +1 | — |
| Q1 2025 | 12 | -1 | 10.37M | $387.41M | — | −1 |
| Q4 2024 | 13 | +4 | 9.16M | $415.03M | +4 | — |
| Q3 2024 | 8 | -5 | 7.45M | $437.40M | — | −5 |
| Q2 2024 | 13 | — | 6.20M | $244.16M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.55M | — | $139.57M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 768.22K | — | $30.23M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 768.22K | — | $30.23M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 740.86K | — | $29.16M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 740.86K | — | $29.16M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 302.22K | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 269.23K | — | $10.59M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 156.20K | — | $6.15M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 116.32K | — | $4.58M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 97.06K | — | $3.82M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 81.95K | — | $3.22M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 81.95K | — | $3.22M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 52.03K | — | $2.05M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 50.00K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Norges Bank ✦ (passief) | 12.12K | — | $476,961 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 11.54K | — | $453,902 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 11.54K | — | $453,902 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 224 houders, 77.95M aandelen, $5.58B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
9.8% van klasse · Originele SEC-indiening bekijken ↗